Back to Rankings

AUPH

AuriniaC
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-22
View Chart
+
Peers tracked
10
U.S. public peers
Grade Position
In line
vs peer average
AUPH vs peer average
55/100
AUPH vs. peer average (C vs. C)
Grade spread
B 2 · C 4 · D 3 · F 1
Graded peers loaded
Coverage
10 graded
100% of tracked

Peer overview

GILD is the first available peer comparator.

Gilead is a useful commercial-biopharma comp for specialty-drug execution and capital allocation, but it is not a direct lupus nephritis peer, so read-through is limited.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerGILDGilead Sciences
AUPH
Aurinia
GILD
Gilead Sciences
Grade
C
C
Momentum
27
28
Value
66
65
Sentiment
55
56
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Mixed

Grade position vs GILD

AUPH / GILD
Grade Position
In line
AUPH vs. peer average (C vs. C)
55/100
Momentum
27
GILD
Value
66
AUPH
Sentiment
55
GILD

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs AUPH
1
GILD
GILD
C
60/100
Even
2
AMGN
AMGN
D
40/100
+1
3
NBTX
Nanobiotix SA ADR
F
20/100
+2
4
AMLX
Amylyx Pharmaceuticals Inc Common
C
60/100
Even
5
RAPP
Rapport Therapeutics Inc Common
D
40/100
+1
GILD is the first peer returned for this comparison set.